| scholarly article | Q13442814 |
| P50 | author | John P. Roberts | Q110682405 |
| Jennifer L Dodge | Q117272215 | ||
| P2093 | author name string | Varun Saxena | |
| Francis Yao | |||
| Bilal Hameed | |||
| Prashant Kotwani | |||
| P2860 | cites work | Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials | Q26778552 |
| Cannabinoids for Medical Use | Q29391539 | ||
| A modified poisson regression approach to prospective studies with binary data | Q29615575 | ||
| Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes | Q34088634 | ||
| Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review | Q34481944 | ||
| Obesity and cannabis use: results from 2 representative national surveys | Q34631834 | ||
| Endocannabinoids in liver disease | Q34776919 | ||
| Influence of cannabis use on severity of hepatitis C disease | Q35250832 | ||
| Estimating the association between metabolic risk factors and marijuana use in U.S. adults using data from the continuous National Health and Nutrition Examination Survey | Q35572485 | ||
| Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis | Q37085008 | ||
| The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects | Q37236871 | ||
| Cannabis use and obesity and young adults | Q37799380 | ||
| Alcohol and substance use in liver transplant patients | Q37950058 | ||
| Review article: the endocannabinoid system in liver disease, a potential therapeutic target | Q38194626 | ||
| Role of cannabis in digestive disorders. | Q38993604 | ||
| Recreational marijuana use is not associated with worse outcomes after renal transplantation. | Q39524644 | ||
| Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women | Q40659740 | ||
| Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient | Q41019002 | ||
| The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report. | Q41178764 | ||
| Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). | Q41346056 | ||
| High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana. | Q41434713 | ||
| Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. | Q43047280 | ||
| Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. | Q43476058 | ||
| Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant | Q45152565 | ||
| Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). | Q46101257 | ||
| Marijuana use in potential liver transplant candidates | Q46207646 | ||
| Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease | Q46301558 | ||
| Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. | Q46343023 | ||
| National survey of provider opinions on controversial characteristics of liver transplant candidates. | Q46455833 | ||
| Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. | Q54122584 | ||
| Transplantation and Marijuana Use | Q87107578 | ||
| Marijuana and Listing for Heart Transplant: A Survey of Transplant Providers | Q87893921 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2018-01-10 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | History of marijuana use does not affect outcomes on the liver transplant waitlist |
| Q98290628 | A Review of the Prevalence of Illicit Substance Use in Solid-Organ Transplant Candidates and the Effects of Illicit Substance Use on Solid-Organ Transplant Treatment Outcomes |
| Q91789081 | Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders |
Search more.